Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
DASA | RCV002221977 | SCV002499413 | likely pathogenic | Combined oxidative phosphorylation deficiency 55 | 2022-04-10 | criteria provided, single submitter | clinical testing | The c.3459C>G;p.(Tyr1153*) variant creates a premature translational stop signal in the POLRMT gene. It is expected to result in an absent or disrupted protein product -PVS1. This variant is not present in population databases (rs200224860- gnomAD; ABraOM no frequency - http://abraom.ib.usp.br) - PM2. In summary, the currently available evidence indicates that the variant is likely pathogenic. |